Keros Therapeutics, Inc. (KROS): SC 13G/A filed Feb 16, 2021

Form type

SC 13G/A

Filing date

Feb 16, 2021

Accession number

0000935836-21-000174

Filer

Keros Therapeutics, Inc. (CIK 1664710)